HNF1B and endometrial cancer risk: Results from the page study

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Setiawan, Veronica Wendy ^a   Haessler, Jeffrey ^b   Schumacher, Fredrick ^a   Cote, Michele L ^c   Deelman, Ewa ^d   Fesinmeyer, Megan D ^b   Henderson, Brian E ^a   Jackson, Rebecca D ^e   Vöckler, Jens S ^d   Wilkens, Lynne R ^f   Yasmeen, Shagufta ^g   Haiman, Christopher A ^a   Peters, Ulrike ^b   Marchand, Loïc ^f   Kooperberg, Charles ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CANCER; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAWAIIAN; HISPANIC; HISTOLOGY; HNF1B GENE; HORMONAL THERAPY; HOX GENE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PARITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TUMOR CLASSIFICATION; CASE CONTROL STUDY; COHORT ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; ETHNOLOGY; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POPULATION GENETICS; STATISTICS;

HEPATOCYTE NUCLEAR FACTOR 1BETA; HNF1B PROTEIN, HUMAN;

AGED; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GENETICS, POPULATION; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84856405619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030390     Document Type: Article

References (20)

1. Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, et al. (2011) Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 43: 451-454.
2. Elliott KS, Zeggini E, McCarthy MI, Gudmundsson J, Sulem P, et al. (2010) Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One 5: e10858.
3. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977-983.
4. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
5. Matise TC, Ambite JL, Buyske S, Carlson CS, Cole SA, et al. (2011) The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol 174: 849-859.
6. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, et al. (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151: 346-357.
7. (1998) Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 19: 61-109.
8. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, et al. (2003) Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13: S122-128.
9. Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, et al. (2010) Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 21: 1851-1856.
10. Prat J, (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35: 649-662.
11. Ronnett BM, Zaino R, Ellenson LH, Kurman RJ, (2002) Endometrial Cancer. In: Kurman RJ, editors. Blaustein's Pathology of the Female Genital Tract. Fifth ed New York Springer pp. 501-559.
12. Sherman ME, (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308.
13. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
14. Bach I, Yaniv M, (1993) More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO J 12: 4229-4242.
15. Edghill EL, Bingham C, Ellard S, Hattersley AT, (2006) Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet 43: 84-90.
16. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, et al. (1997) Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384-385.
17. Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL, (2004) Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 113: 913-923.
18. Harries LW, Perry JR, McCullagh P, Crundwell M, (2010) Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer. BMC Cancer 10: 315.
19. Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, et al. (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169: 937-945.
20. Cook LS, Weiss NS, Doherty JA, Chen C, (2006) Endometrial Cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. Third ed New York Oxford University Press pp. 1027-1043.